Suchergebnisse - "Tetsu Kobayashi"

PubPharm (28)

1

Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection

in: Pharmaceuticals | 2023

von Yurie Kogue | Hiroyasu Kobayashi | Yutaka Nakamura | +10

2

Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression

in: International Journal of Molecular Sciences | 2023

von Ryo Inoue | Taro Yasuma | Valeria Fridman D’Alessandro | +11

3

Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis

in: Gut Pathogens | 2023

von Ryo Nishiwaki | Ichiro Imoto | Satoko Oka | +17

4

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

in: Nature Communications | 2022

von Corina N. D’Alessandro-Gabazza | Taro Yasuma | Tetsu Kobayashi | +29

5

Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report

in: Pharmaceuticals | 2022

von Yoichi Nishii | Kazuki Furuhashi | Kentaro Ito | +9

6

The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma

in: Cells | 2022

von Chisa Inoue | Taro Yasuma | Corina N. D’Alessandro-Gabazza | +14

7

Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions

in: International Journal of Molecular Sciences | 2022

von Valeria Fridman D’Alessandro | Atsuro Takeshita | Taro Yasuma | +10

8

Place Branding in the Age of the New Normal:

in: Maketingu Janaru | 2021

von Tetsu Kobayashi

9

Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus

in: Cells | 2021

von Yuko Okano | Atsuro Takeshita | Taro Yasuma | +8

10

Second‐line therapy with first‐ or second‐generation tyrosine kinase inhibitors in EGFR‐mutated non‐small cell lung cancer patients with T790M‐negative or unidentified mutation

in: Thoracic Cancer | 2021

von Tadashi Nishimura | Tomohito Okano | Masahiro Naito | +10